Stockreport

BRIEF-Acorda discontinues Tozadenant development program [Reuters]

Acorda Therapeutics, Inc.  (ACOR) 
Last acorda therapeutics, inc. earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: acorda.com/investors
PDF BRIEF-Acorda discontinues Tozadenant development program | Reuters Reuters Staff 1 Min Read Nov 20 (Reuters) - Acorda Therapeutics Inc: * Acorda discontinues tozadenant [Read more]